Tuesday, April 05, 2005 11:24:11 PM
The pps says nothing about the company.
The pps IS the company.
You can't possibly pretend that the future, if not the near term survival, of the company is not tied DIRECTLY to the pps.
Whether the future 'du jour' is based on the $25 Million to purchase Biofrontera or the $20 Million needed for a drug trial, that money HAS to be extracted from the investment community via sales of shares.
Forgetting the obvious dilutive effects of printing shares, $20 Million dollars will require 2 Billion shares and a MINIMUM share price of one cent.
Neither value is currently viable. The pps MUST respond if the company is to survive.
They are inextricably connected.
FEATURED SMX and FinGo Enter Into Collaboration Mandate to Develop a Joint 'Physical to Digital' Platform Service • Nov 7, 2024 8:48 AM
FEATURED SBC Medical Group Holdings and MEDIROM Healthcare Technologies Announce Business Alliance • Nov 7, 2024 7:00 AM
Rainmaker Worldwide Inc. (OTC: RAKR) Announces Successful Implementation of 1.6 Million Liter Per Day Wastewater Treatment Project in Iraq • RAKR • Nov 7, 2024 8:30 AM
VAYK Confirms Insider Buying at Open Market • VAYK • Nov 5, 2024 10:40 AM
Rainmaker Worldwide Inc. Announces Strategic Partnership Between Miranda Water Technologies and Fleming College • RAKR • Nov 4, 2024 12:03 PM
North Bay Resources Announces Assays up to 9.5% Copper at Murex Copper Project, British Columbia • NBRI • Nov 4, 2024 9:00 AM